This is a great article from dvm360.com and while it goes into a lot of detail regarding clinical signs, I wanted to share it simply because most of us don’t think twice if we are out for a walk and our dog gobbles up some mushrooms in the grass. Just be careful and know it’s probably better to keep your dog away from those mushrooms – unless you are a mushroom expert and you can identify the species of mushroom just by looking at it. I certainly can’t!
While only a few mushroom species are toxic to dogs and cats, mushroom poisoning has found its way to the mainstream news recently after celebrity Dwayne “The Rock” Johnson shared that his French bulldog, Brutus, had died after ingesting mushrooms. There have also been reports of a pocket of several apparent mushroom poisonings in Saskatchewan.
Outdoor dogs, especially those allowed to roam freely through woods and fields, are at the greatest risk of poisoning. A few of these “field” mushrooms pose an additional hazard as they have an enticing fishy smell or have toxins present only in the natural, uncooked state. In some instances, indoor or indoor-outdoor dogs and cats may be at greatest risk simply because the mushrooms are found in their environment. Recreational or hallucinogenic mushrooms are an excellent example of this.
Ingestion of toxic mushrooms may result in severe clinical signs or death. In general, all mushroom ingestions in veterinary patients should be considered toxic unless the mushroom is accurately and rapidly identified by a person trained in mycology. Clinical signs associated with mushroom poisoning depend on the species of mushroom ingested, specific toxin within that mushroom, amount ingested, and age and size of animal. Early nonspecific signs include vomiting, diarrhea, abdominal pain, ataxia or incoordination, depression, tremors and seizures.
Mushrooms known to cause poisoning can be roughly divided into five broad categories based on clinical signs. Included in increasing order of toxicity are those that cause gastrointestinal irritation, hallucinations, muscarinic reactions resulting in SLUDGE (salivation, lacrimation, urination, diarrhea, gastrointestinal distress and emesis), psychotropic activity or seizures, and hepatic necrosis or kidney failure. The degree of toxicity and expected outcome differ for each general category and concentration of toxin present.
Mushrooms found in this category include those in the genera Agaricus,Boletus, Chlorophyllum, Entoloma, Lactarius, Omphalotus, Rhodophyllus,Scleroderma and Tricholoma. The specific toxin for most of these mushrooms is unknown. Abdominal pain, vomiting and diarrhea occur within 15 minutes to two hours of ingestion and resolve spontaneously within a few hours. Rarely, the signs last for 24 to 48 hours. Most animals improve without treatment, but supportive care in the form of antiemetics, histamine-2 antagonists (H2 blockers) and intravenous fluids is indicated for persistent signs. The prognosis for a full recovery is excellent, and poisoning is rarely fatal.
Psilocybe, Panaeolus, Conocybe and Gymnopilus species mushrooms grow primarily in fields and pastures in the northwestern and southeastern United States. Often referred to as magic mushrooms, they are also grown in basements and personal greenhouses for recreational use. Psilocybin and psilocin, the known toxins, are hallucinogens that readily cross the blood-brain barrier into the central nervous system (CNS) where they stimulate serotonin receptors. In dogs, ataxia, weakness, vocalization, nystagmus, abnormal mentation, aggression and increased body temperature occur within 15 minutes to two hours. The signs in most dogs are short-lived, lasting only for four to six hours, although some cases may take 24 to 48 hours for full resolution of signs. Emesis may be useful if early and clinical signs have not occurred. Treatment is supportive and includes anticonvulsants, intravenous fluids and attention to thermoregulation. The prognosis is generally good, although deaths have been reported.
Mushrooms in the genera Inocybe and Clitocybe species are the most common members of this group. Both are found worldwide. Inocybe species tend to grow under or around conifers or broad-leafed trees, and Clitocyte species grow in grasslands or on the forest floor. Muscarine, the toxin, competes with acetylcholine at its receptor-binding sites. Once bound, muscarine acts like acetylcholine but is not degraded by acetylcholinesterase. Fortunately, muscarine does not cross the blood-brain barrier, so most effects are peripheral.
Depending on the amount of muscarine present, the signs of poisoning occur anywhere from a few minutes to two hours of ingestion and last for several days. Commonly observed signs include SLUDGE, but other reported signs include abdominal pain, miosis and bradycardia.
If the animal has not already vomited, induce emesis. Further decontamination with activated charcoal is usually not practical because of the rapid onset of clinical signs. Intravenous fluids should be administered for dehydration and atropine (0.2 to 2 mg/kg, one-quarter intravenously and the remainder subcutaneously or intramuscularly) given as needed for the SLUDGE syndrome. Drying of respiratory secretions is a useful guide for repeat atropine dosing. The prognosis is generally good but varies depending on the amount of muscarine in the mushrooms, severity of signs, and response to atropine. It is important to note, however, that a single Inocybeand Clitocybe species mushroom may be lethal if muscarine in the mushroom is high.
Psychotropic activity and seizures
The most common species of mushrooms in this broad category are Amanita pantherina and Amanita muscaria. They are found throughout the United States but are especially common in the deciduous and coniferous forests of the Pacific Northwest. Other less common species include the Amanita gemmata, Amanita smithiana, Amanita strobiliformis and Tricholoma muscarium. A few of these mushrooms are grown or kept by people for recreational use, and cats as well as dogs have been poisoned. Technically referred to as isoxazoles, the two major toxins, ibotenic acid and muscimol, readily cross the blood-brain barrier. Ibotenic acid mimics the excitatory amino acid glutamic acid, acting most strongly at NMDA glutamate receptors, and muscimol is potent a GABA agonist.
Clinical signs in dogs generally occur within 30 to 90 minutes of ingestion, are related to the central nervous system, and include lethargy, vocalization, incoordination, panting, labored breathing, paddling, aimless chewing, hyperactivity, muscle tremors and seizures. Signs may occur as early as 15 minutes in cats and vary from profound depression to excitation and muscle tremors.
Emesis is not recommended because of the rapid onset of neurologic signs. Gastric lavage followed by activated charcoal is useful if performed early after an ingestion. Treatment is primarily symptomatic and supportive, with special attention given to medications chosen for seizure control. Benzodiazepines such as diazepam and midazolam should be used carefully as they are GABAnergic in nature and may exacerbate effects; barbiturates may cause worsening of CNS depression and respiratory depression requiring mechanical ventilation. The prognosis depends on the amount of toxin present and mushroom ingested but is normally good with aggressive supportive care. Death may occur after ingestion of a single mushroom if the concentration of toxins is high enough.
Hepatic necrosis and kidney failure
Common genera of mushrooms in this group include Amanita, Galerina andLepiota, with Amanita phalloides (death cap or death angel), most widely known. The death cap is frequently found around trees (e.g. birch, oak) in warm, humid years in the northeastern United States, Pacific Northwest and San Francisco Bay Area. These cyclopeptide-containing mushrooms are among the most poisonous in North American and very few dogs or cats survive ingestion. Amanitins, the primary toxins, are heat-stable and not degraded by the acid stomach pH, which means they are poisonous both as fresh and cooked mushrooms. Amanitins work by inhibiting RNA polymerase II and ribosomal protein synthesis. The net result is cell death, especially of hepatocytes but also of intestinal crypt cells and proximal renal tubule cells where the metabolic rate is high.
The clinical signs occur in different phases, and it is vitally important that veterinarians treating animals with mushroom exposures understand the time frame so early and aggressive treatment is provided. The earliest signs are gastrointestinal and include severe abdominal pain, vomiting and bloody diarrhea. They are often delayed for six to 24 hours after ingestion. This phase typically lasts for 24 to 48 hours and is followed by a quiet phase of 12 to 24 hours. During this time, liver enzyme activities increase until fulminant liver failure, hypoglycemia, coagulopathy, encephalopathy, coma and death occur. Animals that survive the hepatic phase develop polyuria, polydipsia, vomiting and anorexia and die of proximal and distal renal tubule necrosis. A few dogs die early in the poisoning, but for most, death occurs three to five days after ingestion.
Early diagnosis and treatment are critical if the dog or cat is to survive. There is currently no known antidote. Animals should be treated as early as possible and not just monitored to see if clinical signs develop. If vomiting does not occur, emesis should be induced and followed with three doses of activated charcoal. Intravenous fluid therapy including dextrose, antiemetics, H2 blockers and phytonadione are useful for symptomatic and supportive care. Liver protectants such as silymarin, S-adenosyl methionine (SAME), N-acetylcysteine and vitamin E all warrant use. An experimental procedure to drain the gallbladder was used to successfully treat a poisoned dog with A. phalloides but has not yet been fully evaluated. The prognosis for recovery in dogs and cats is very poor with liver transplants the only known cure.